Guoli Wei
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 11
-
- Gut microbiota and health 3
- Co-authors
- Shicai Ye (5 shared papers)Weiyun Wu (3 shared papers)Hao Wang (3 shared papers)Yu Zhou (4 shared papers)Xiao Feng (2 shared papers)Wenkai Tan (3 shared papers)Lingchang Li (16 shared papers)Jiege Huo (21 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (3 papers)Frontiers in Neurology (2 papers)Chemical Engineering Journal (2 papers)BMC Cancer (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Guoli Wei
47 papers receiving 741 citations
Peers
Comparison fields: 5 of 107
- Cancer Research 229
- Pharmacology 59
- Oncology 145
- Molecular Biology 347
- Sensory Systems 19
Countries citing papers authored by Guoli Wei
This map shows the geographic impact of Guoli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoli Wei more than expected).
Fields of papers citing papers by Guoli Wei
This network shows the impact of papers produced by Guoli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoli Wei. The network helps show where Guoli Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoli Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 143 | |
| 2 | 2012 | 107 | |
| 3 | 2022 | 61 | |
| 4 | 2013 | 52 | |
| 5 | 2021 | 40 | |
| 6 | 2019 | 32 | |
| 7 | 2021 | 28 | |
| 8 | 2020 | 19 | |
| 9 | 2021 | 19 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2024 | 14 | |
| 14 | 2022 | 14 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2024 | 11 | |
| 19 | 2024 | 11 | |
| 20 | 2023 | 10 |
About Guoli Wei
Guoli Wei is a scholar working on Oncology, Molecular Biology, Pharmacology, Cancer Research and Pharmacology, having authored 48 papers that have together received 753 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Gut microbiota and health (3 papers), Plant-based Medicinal Research (3 papers), Pharmacological Effects of Natural Compounds (3 papers), MicroRNA in disease regulation (3 papers), Flavonoids in Medical Research (2 papers), Traditional Chinese Medicine Studies (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (229 citations), Pharmacology (59 citations), Oncology (145 citations), Molecular Biology (347 citations) and Sensory Systems (19 citations). Guoli Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shicai Ye, Weiyun Wu, Hao Wang, Yu Zhou, Xiao Feng, Wenkai Tan, Lingchang Li, Jiege Huo, Jialin Yu and Feng Wu. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Frontiers in Neurology, Chemical Engineering Journal, BMC Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.